Koyfin Home > Directory > Health Care > Incyte Corp > EBITDA / Interest Expenses

Incyte Corp EBITDA / Interest Expenses Chart (INCY)

Incyte Corp annual/quarterly EBITDA / Interest Expenses from 2010 to 2020. EBITDA / Interest is the interest coverage ratio and measures the ability of a company to service its debt.
  • Incyte Corp EBITDA / Interest Expenses for the quarter ending June 06, 2020 was $420m a 38.27% increase of 161m year over year
  • Incyte Corp EBITDA / Interest Expenses for the last 12 months ending June 06, 2020 was $-49m a 709.38% decrease of -350m year over year
  • Incyte Corp Annual EBITDA / Interest Expenses for 2019 was $265m a 48.88% increase of 129m from 2018
  • Incyte Corp Annual EBITDA / Interest Expenses for 2018 was $135m a 118.42% increase of 160m from 2017
  • Incyte Corp Annual EBITDA / Interest Expenses for 2017 was $-25m a 119.78% decrease of -30m from 2016
Other Ratios Metrics:
  • Incyte Corp Total Debt / Capital for the quarter ending December 12, 2018 was $1m a -63.76% decrease of -1m year over year
  • Incyte Corp Other Liabilities for the quarter ending December 12, 2018 was $287m a 2.41% increase of 7m year over year
  • Incyte Corp Total Debt / Equity for the quarter ending December 12, 2018 was $1m a -64.69% decrease of -1m year over year
View Chart On Koyfin

Quarterly INCY EBITDA / Interest Expenses Data

06/2020$420m
03/2020$-1,065m
12/2019$192m
09/2019$259m
06/2019$386m
03/2019$292m
12/2018$291m
09/2018$122m
06/2018$260m
03/2018$-123m

Annual INCY EBITDA / Interest Expenses Data

2019$265m
2018$135m
2017$-25m
2016$5m
2015$1m
2014$0m
2013$0m
2012$0m
2011$-3m
2010$1m